Pharmacokinetic/pharmacodynamic (PK/PD) Characteristics of Veliparib with and without Temozolomide in Patients with Hematological Malignancies

被引：0
|
作者：
Singh, Renu [1 ]
Gopalakrishnan, Mathangi [1 ]
Kiesel, Brian F. [2 ]
Greer, Jacqueline M. [3 ]
Karp, Judith E. [3 ]
Gojo, Ivana [3 ]
Gobburu, Jogarao [1 ]
Rudek, Michelle A. [3 ]
Beumer, Jan H. [2 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-47
引用
收藏
页码：S31 / S32
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetic–pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies
    K. Nomura
    Y. Fujimoto
    Y. Kanbayashi
    K. Ikawa
    M. Taniwaki
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27 : 1141 - 1143
  • [2] Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies
    Nomura, K.
    Fujimoto, Y.
    Kanbayashi, Y.
    Ikawa, K.
    Taniwaki, M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (11) : 1141 - 1143
  • [3] COMBINED PHARMACOKINETIC PHARMACODYNAMIC (PK/PD) MODELING
    COLBURN, WA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (09): : 769 - 771
  • [4] Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models
    Zhang, Longfei
    Xie, Hongbing
    Wang, Yongqiang
    Wang, Hongjuan
    Hu, Jianhe
    Zhang, Gaiping
    FRONTIERS IN VETERINARY SCIENCE, 2022, 9
  • [5] Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling
    Meibohm, B
    Derendorf, H
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1997, 35 (10) : 401 - 413
  • [6] A new pharmacokinetic/pharmacodynamic model (PK/PD) for mivacurium
    Laurin, J
    Nekka, F
    Donati, F
    Varin, F
    ANESTHESIOLOGY, 1996, 85 (3A) : A323 - A323
  • [7] Ciprofloxacin Inhale - A Pharmacokinetic(PK)/pharmacodynamic(PD) Rationale
    Stass, H.
    Dalhoff, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [8] Pharmacokinetic and pharmacodynamic (PK/PD) evaluation of cefazolin in dog
    Cagnardi, P.
    Ravasio, G.
    Acocella, F.
    Villa, R.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 : 123 - 123
  • [9] RELEVANT KEY PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) GENES
    Malik, Salma
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S71 - S72
  • [10] Population pharmacokinetic (PK)-pharmacodynamic (PD) model for gefitinib in cancer patients.
    Li, J
    Karlsson, MO
    Brahmer, J
    Cusatis, G
    Hidalgo, M
    Baker, SD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 212S - 212S
12345